VolitionRx (VNRX) director logs 12,000-share stock grant
Rhea-AI Filing Summary
VolitionRx Ltd director Guy Archibald Innes filed a Form 4 reporting equity compensation tied to prior restricted stock unit (RSU) awards. On March 17, 2025 he was granted 40,000 RSUs under the 2024 Stock Incentive Plan, subject to corporate performance and time-based vesting conditions. Certain performance goals were achieved, so rights with respect to 12,000 RSUs vested, while the remaining 28,000 RSUs were cancelled on June 30, 2025 and January 22, 2026.
Following the reported transaction, Innes directly holds 1,074,967 shares of common stock. He also has indirect interests, including 1,400,000 shares held by The Innes Family Bare Trust 2023 and 356,000 shares held by The Dill Faulkes Educational Trust Limited, where he disclaims beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 12,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- On March 17, 2025, the reporting person was awarded 40,000 restricted stock units ("RSUs") under the Issuer's 2024 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to June 30, 2025 and December 31, 2025 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 12,000 RSUs vesting. The RSUs are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. The rights with respect to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026, respectively. These shares of Common Stock are beneficially owned by The Innes Family Bare Trust 2023, which is a separate legal entity, of which the reporting person is the Trustee, for the benefit of his children. These shares of Common Stock are beneficially owned by The Dill Faulkes Educational Trust Limited ("DFET"), a UK registered charity. The reporting person serves as a director and trustee of DFET and shares voting and dispositive control over these shares but disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
FAQ
What did the VolitionRx (VNRX) Form 4 filed by Guy Archibald Innes report?
The Form 4 shows that director Guy Archibald Innes had rights vest with respect to 12,000 restricted stock units (RSUs) from a prior 40,000 RSU grant, with the remaining 28,000 RSUs cancelled under the company’s 2024 Stock Incentive Plan.
How many VolitionRx RSUs vested and how many were cancelled for Guy Innes?
From a 40,000 RSU award granted on March 17, 2025, performance conditions were met for 12,000 RSUs. The rights to the remaining 28,000 RSUs did not vest and were cancelled on June 30, 2025 and January 22, 2026.
What is the vesting schedule for Guy Innes’s 12,000 VolitionRx RSUs?
The 12,000 RSUs that met performance goals are subject to a further 3-year time-based schedule, vesting in three equal installments of 4,000 units on each of March 17, 2026, 2027 and 2028.